General information about company

Scrip code532815
NSE SymbolSMSPHARMA
MSEI SymbolNOTLISTED
ISININE812G01025
Name of the entitySMS PHARMACEUTICALS LIMITED
Date of start of financial year01-04-2024
Date of end of financial year31-03-2025
Reporting Quarter TypeQuarterly
Date of Quarter Ending31-12-2024
Type of companyEquity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity?Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity?Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity?Yes
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity?Yes
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity?NoThere are no material tax litigations or disputes in terms of sub para 8 of Para B of Part A of Schedule III
Risk management committeeApplicable
Market Capitalisation as per immediate previous Financial YearTop 1000 listed entities
Is SCORE ID Available ?Yes
SCORE Registration IDs00403
Reason For No SCORE ID
Type of SubmissionOriginal
Remarks (website dissemination)
Remarks for Exchange (not for Website Dissemination)



Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatoryTextual Information(1)
Whether the listed entity has a Regular ChairpersonYes
Whether Chairperson is related to MD or CEOYes
SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of Birth
1MrRamesh Babu PotluriADFPP2514C00166381Executive DirectorChairpersonMD23-06-1959
2MrShravan KudaravalliAAZPK5473C06905851Non-Executive - Independent DirectorNot Applicable28-04-1978
3MrSarvepalli SrinivasAKIPS7692B02292051Non-Executive - Independent DirectorNot Applicable29-06-1962
4MrVamsi Krishna PotluriAQSPP0412F06956498Executive DirectorNot Applicable15-08-1988
5MrTrilok PotluriAQSPP0471A07634613Non-Executive - Non Independent DirectorNot Applicable27-12-1989
6MrSunkara Venkata Satya Shiva PrasadAHHPP2222R10404277Non-Executive - Non Independent DirectorNot Applicable15-09-1961
7MrSuresh Kumar GangavarapuACGPG1928H00183128Non-Executive - Independent DirectorNot Applicable22-01-1951
8MrsShanti Sree BolleniACEPB2943H07092258Non-Executive - Independent DirectorNot Applicable17-05-1962

I. Composition of Board of Directors

Disqualification of Directors under section 164 of the Companies Act, 2013

SrWhether the director is disqualified?Start Date of disqualificationEnd Date of disqualificationDetails of disqualificationCurrent status
1NoActive
2NoActive
3NoActive
4NoActive
5NoActive
6NoActive
7NoActive
8NoActive

I. Composition of Board of Directors

SrWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & reg. 17A(2)]Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Reason for CessationNotes for not providing PANNotes for not providing DIN
1NA30-08-199001-10-202101000
2NA20-09-201826-05-2023191111
3NA12-08-201912-08-202441110
4NA05-06-202001-07-202001010
5NA12-08-202401010
6NA12-08-202402111
7Yes30-09-202412-08-20244.21110
8NA12-08-20244.266103


Text Block

Textual Information(1) Mr. Vamsi Krishna Potluri appointed as an Additional Director of the Company, effective 5th June, 2020 and he has appointed as a Whole Time Director designated as Executive Director of the Company, for a period of 5 (five) years commencing from 1st July, 2020.



Annexure 1

II. Composition of Committees

Disclosure of notes on composition of committees explanatoryTextual Information(1)

Annexure 1 Text Block

Textual Information(1)The Nomination and Remuneration Committee was reconstituted on 08.11.2024 by removing Mr. Trilok Potluri as a member of the Committee. He served as a member from 12.08.2024 to 07.11.2024. The same was informed to the exchange as part of the outcome of the Board Meeting held on 08.11.2024.


Audit Committee Details

Whether the Audit Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
106905851Shravan KudaravalliNon-Executive - Independent DirectorChairperson26-05-2018
200183128Suresh Kumar GangavarapuNon-Executive - Independent DirectorMember12-08-2024
306956498Vamsi Krishna PotluriExecutive DirectorMember12-08-2024


Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
107092258Shanti Sree BolleniNon-Executive - Independent DirectorChairperson12-08-2024
200183128Suresh Kumar GangavarapuNon-Executive - Independent DirectorMember12-08-2024
310404277Sunkara Venkata Satya Shiva PrasadNon-Executive - Non Independent DirectorMember12-08-2024
407634613Trilok PotluriNon-Executive - Non Independent DirectorMember12-08-202408-11-2024


Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
110404277Sunkara Venkata Satya Shiva PrasadNon-Executive - Non Independent DirectorChairperson12-08-2024
207634613Trilok PotluriNon-Executive - Non Independent DirectorMember12-08-2024
302292051Sarvepalli SrinivasNon-Executive - Independent DirectorMember12-08-2019
407092258Shanti Sree BolleniNon-Executive - Independent DirectorMember12-08-2024


Risk Management Committee

Whether the Risk Management Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100166381Ramesh Babu PotluriExecutive DirectorChairperson28-05-2021
206956498Vamsi Krishna PotluriExecutive DirectorMember28-05-2021
306905851Shravan KudaravalliNon-Executive - Independent DirectorMember28-05-2021


Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100166381Ramesh Babu PotluriExecutive DirectorChairperson01-12-2008
206905851Shravan KudaravalliNon-Executive - Independent DirectorMember12-08-2019
302292051Sarvepalli SrinivasNon-Executive - Independent DirectorMember12-08-2019


Other Committee

SrDIN NumberName of Committee membersName of other committeeCategory 1 of directorsCategory 2 of directorsRemarks

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Disclosure of notes on meeting of board of directors explanatoryTextual Information(1)
Sr. No.Date(s) of meeting (if any) in the previous quarterDate(s) of meeting (if any) in the current quarterMaximum gap between any two consecutive (in number of days)Notes for not providing DateWhether requirement of Quorum met (Yes/No)Total Number of Directors as on date of the meetingNumber of Directors present* (All directors including Independent Director)No. of Independent Directors attending the meeting*
105-08-2024Yes653
208-11-202494Yes884



Text Block

Textual Information(1)During the quarter the two circular resolutions on 18.10.2024 & 11.12.2024 passed by the Board of Directors of the Company.



Annexure 1

IV. Meeting of Committees

Disclosure of notes on meeting of committees explanatory
SrName of CommitteeDate(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)Maximum gap between any two consecutive (in number of days)Name of other committeeReson for not providing dateWhether requirement of Quorum met (Yes/No)Total Number of Directors in the Committee as on date of the meetingNumber of Directors Present (All Directors including Independent Director)No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1Audit Committee05-08-2024Yes3320
2Audit Committee07-11-202493Yes3320
3Stakeholders Relationship Committee08-11-20240Yes4420



Annexure 1

V. Affirmations

SrSubjectCompliance status (Yes/No)
1The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015Yes
2The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit CommitteeYes
3The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committeeYes
4The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committeeYes
5The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities)Yes
6The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
7The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
8This report and/or the report submitted in the previous quarter has been placed before Board of Directors.Yes

Annexure 1

SrSubjectCompliance status
1Name of signatoryRamesh Babu Potluri
2DesignationManaging Director



Details of Cyber security incidence

Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarterNo
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr.Date of the eventBrief details of the event



Signatory Details

Name of signatoryRamesh Babu Potluri
Designation of personManaging Director
PlaceHyderabad
Date10-02-2025



Investor Grievance Details

No. of investor complaints pending at the beginning of Quarter0
No. of investor complaints received during the Quarter0
No. of investor complaints disposed off during the Quarter0
No. of investor complaints those remaining unresolved at the end of the Quarter0



Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies- The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below:

Any Other Information for Disclosure of Acquisition of Shares or Voting Rights in Unlisted CompaniesTextual Information(1)
Sr. No.Name of the unlisted company in which shares or voting rights have been acquiredDate of acquisitionAggregate holding (% shares or voting rights) as at the end of the previous quarter% shares or voting rights acquired during the quarterAggregate holding (% shares or voting rights) as at the end of the quarter
1SMS PEPTIDES PRIVATE LIMITED01-11-202409393



Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies- The details of acquisition of shares or voting rights in unlisted companies during the quarter in terms of sub-para 1 of para A of Part A of Schedule III are given below: Text Block

Textual Information(1)During the quarter the Company SMS Pharmaceuticals Limited incorporated a Subsidary Company Namely SMS Peptides Private Limited is a Subsidiary Company to SMS Pharmaceuticals Limited with holding 93% of equity stake. Same was duly intimated to the Stock Exchanges as part of outcome of the Board Meeting on 05th August, 2024 and also on 01st November, 2024 on the day of incorporation of Subsidiary Company.

Disclosure of Imposition of Fine or Penalty The details of imposition of fine or penalty during the quarter in terms of sub-para 20 of para A of Part A of Schedule III are given below:

Any Other Information for Disclosure of Imposition of Fine or Penalty
Sr. No.Name of the authorityNature and details of the action(s) taken or order(s) passedDate of receipt of direction or order, including any ad interim or interim orders, or any other communication from the authorityDetails of the violation(s)/ contravention(s) committed or alleged to be committedImpact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible
1BSE Limited and National Stock Exchange of India LimitedFine of Rs. 2,000 per day from 12th August, 2024 to 30th September, 2024 imposed by BSE Limited & National Stock Exchange of India Ltd, for non-compliance.21-11-2024Non-compliance of Regulation 19(1)(c) of SEBI LODR, with the requirements �at least two-thirds of the Directors shall be Independent Directors� pertaining to the composition of Nomination and Remuneration Committee of the Board for the period from 12th August, 2024 to 07th November, 2024.There is no material impact of such fines on the financial, operation or other activities of the Company.